4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001677036-26-000009
Options or other derivatives
- Director acquired 1,352 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lind Kevin Robert · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +1,352 | $12.29 | $16,616 | 1,352 | D |
Loading xslF345X06/form4-10022026_041018.xml…